Skip to main content

Universal Technical Institute I (UTI) Stock Analysis

SellVALUE-TRAP 1/5Moderate Confidence

Consumer Defensive · Education & Training Services

Earnings in 6 days (2026-05-06). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Analyst target reached at $37.40 — A.R:R is negative (-1.7) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Title IV Programs and veterans' programs (78.0%).

Universal Technical Institute operates 15 UTI campuses in 9 states for transportation and skilled trades programs, and 17 Concorde campuses in 8 states for healthcare programs. Revenue is approximately 78% from Title IV Programs and veterans' programs on a cash basis in fiscal... Read more

$37.40+2.2% A.UpsideScore 4.2/10#15 of 15 Education & Training Services
Stop $34.77Target $38.20(resistance)A.R:R -1.7:1
Analyst target$37.33-0.2%6 analysts
$38.20our TP
$37.40price
$37.33mean
$36
$40

Sell if holding. Analyst target reached at $37.40 — A.R:R is negative (-1.7) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Title IV Programs and veterans' programs (78.0%). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 4.2/10, moderate confidence.

Passes 5/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 6d<=7d. Suitability: aggressive.

Thesis

Rewards
Strong earnings beat streak (4/4)
Risks
Concentration risk — Customer: Title IV Programs and veterans' programs (78.0%)
Analyst target reached - limited upside remaining
Earnings in 6 days (event risk)

Key Metrics

P/E (TTM)37.6
P/E (Fwd)38.8
Mkt Cap$2.0B
EV/EBITDA20.0
Profit Mgn6.3%
ROE17.4%
Rev Growth9.6%
Beta1.33
DividendNone
Rating analysts11

Quality Signals

Piotroski F6/9

Options Flow

P/C0.39bullish
IV73%elevated
Max Pain$20-46.5% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHCustomerTitle IV Programs and veterans' programs78%
    10-K Item 1A: 'Title IV Programs and veterans' programs, from which we derived approximately 78% of our revenues, on a cash basis, in fiscal 2025'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
0.0
Revenue Growth
4.9

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
2.1
Growth Rank
4.7
Quality Rank
4.9

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ev Ebitda
0.0
Forward Pe
2.8
Analyst Target
3.0
Pe
3.3
Peg Ratio
3.6
Ps
8.7
Forward P/E: 38.8xPEG: 3.12
GatesA.R:R -1.7=NEGATIVEEARNINGS PROXIMITY 6d<=7dMomentum 5.3<5.5 (soft — BUY_NOW allowed but watch)Momentum 5.3>=4.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARSuitability: Aggressive
RSI
58 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $34.48Resistance $38.98

Price Targets

$35
$38
A.Upside+2.1%
A.R:R-1.7:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Target reached (-13.1% upside)
! Negative risk/reward — downside exceeds upside
! EARNINGS_PROXIMITY:6d<=7d

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-05-06 (6d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is UTI stock a buy right now?

Sell if holding. Analyst target reached at $37.40 — A.R:R is negative (-1.7) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Title IV Programs and veterans' programs (78.0%). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $34.77. Score 4.2/10, moderate confidence.

What is the UTI stock price target?

Take-profit target: $38.20 (+2.2% upside). Prior stop was $34.77. Stop-loss: $34.77.

What are the risks of investing in UTI?

Concentration risk — Customer: Title IV Programs and veterans' programs (78.0%); Analyst target reached - limited upside remaining; Earnings in 6 days (event risk).

Is UTI overvalued or undervalued?

Universal Technical Institute I trades at a P/E of 37.6 (forward 38.8). TrendMatrix value score: 3.5/10. Verdict: Sell.

What do analysts say about UTI?

11 analysts cover UTI with a consensus score of 4.1/5. Average price target: $37.

What does Universal Technical Institute I do?Universal Technical Institute operates 15 UTI campuses in 9 states for transportation and skilled trades programs, and...

Universal Technical Institute operates 15 UTI campuses in 9 states for transportation and skilled trades programs, and 17 Concorde campuses in 8 states for healthcare programs. Revenue is approximately 78% from Title IV Programs and veterans' programs on a cash basis in fiscal 2025.

Related stocks: TAL (TAL Education Group) · LAUR (Laureate Education, Inc.) · EDU (New Oriental Education & Techno) · PRDO (Perdoceo Education Corporation) · COUR (Coursera, Inc.)